In addition, several preclinical studies showed that activated microglia can enhance tau phosphorylation in animal models of AD and other tauopathies (Bhaskar et al, 2010; Lee et al, 2014; Maphis et al, 2015; Ising et al, 2019). This evidence concerns the gene MAPT and Alzheimer disease.